PO.TB10.01 · 肿瘤生物学

细胞分裂调控巨噬细胞对乳腺上皮的侵入

Cell division regulates macrophage invasion in mammary epithelia

海报缩略图:细胞分裂调控巨噬细胞对乳腺上皮的侵入
编号 2262 展板 11 时间 4/20 09:00–12:00 区域 Section 33 主讲 Emily Pratt, BS;MS
分会场 Tumorigenesis and Early Microenvironmental Trajectories
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Emily A. Pratt, Mariia Akhmanova

Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY

摘要 Abstract

中文摘要
巨噬细胞监视着乳腺上皮,存在于导管的肌上皮层与腔面层之间,在分支形态发生过程中协助组织重塑。随着青春期和妊娠期更多骨髓来源的巨噬细胞到达,这些导管巨噬细胞数量扩增,此时腺体发生广泛重塑、细胞增殖增加,并通过腔面细胞凋亡以维持导管管腔。有趣的是,在三阴性乳腺癌(TNBC)中也可观察到早期巨噬细胞浸润,且与不良预后相关。TNBC相关巨噬细胞与正常乳腺发育过程中导管巨噬细胞的极化状态和组织重塑功能相似,而在腔面型或人表皮生长因子受体2阳性(HER2+)乳腺癌中则不那么常见。虽然乳腺巨噬细胞存在于腺体内已有充分记载,但巨噬细胞在发育和疾病背景下浸润上皮屏障的机制仍不清楚。因此,为填补我们对巨噬细胞生物学理解上的这一空白,我们采用了与活细胞成像兼容的三维乳腺上皮与巨噬细胞共培养体系。我们假设巨噬细胞对上皮完整性的短暂破坏(例如有丝分裂或程序性细胞死亡期间发生的破坏)作出反应,并利用这些短暂的上皮-上皮黏附缺失作为进入上皮区室的机会。为验证这一假设,我们对由健康细胞(MCF10A)和TNBC细胞(MDA-MB-231)生成的三维乳腺上皮球体与巨噬细胞共培养进行了活细胞成像。乳腺腺泡形成极化的管腔,凋亡细胞被挤出至腔隙内,与体内情况类似。乳腺球体提供了一种体外模型,其中凋亡可通过药物驱动,导致上皮更新增加,从而使我们能够模拟乳腺导管的动态状态。我们的数据支持以下假设:巨噬细胞在细胞分裂位点穿越上皮层,这与短暂的连接不稳定性引导巨噬细胞定位的模型一致。在乳腺退化(involution)过程中,腔面上皮细胞发生凋亡并向组织微环境释放"find-me"(找到我)信号。我们假设巨噬细胞对这些局部引诱信号作出反应,利用上皮-上皮细胞黏附的短暂缺失来穿越肌上皮层。总之,这项工作旨在定义调控巨噬细胞浸润乳腺组织的上皮信号,并理解这些过程如何塑造正常发育程序以及TNBC的早期疾病转变。阐明巨噬细胞进入上皮环境的机制,可能为在侵袭性乳腺癌中靶向免疫-上皮相互作用提供新机遇,同时丰富我们对未受重视的免疫-上皮串扰的理解。
查看英文原文 English abstract
Macrophages survey the mammary epithelium and are found between the myoepithelial and luminal layers of the ducts where they aid in tissue remodeling during branching morphogenesis. These ductal macrophages expand as more bone marrow derived macrophages arrive during puberty and pregnancy, when there is extensive remodeling of the gland, increased cell proliferation, and luminal apoptosis to maintain the ductal lumen. Interestingly, early macrophage infiltration is also observed in triple negative breast cancer (TNBC) and is associated with poor prognosis. TNBC-associated macrophages resemble the polarized state and tissue remodeling function of ductal macrophages during normal mammary development and are not as commonly found in luminal or human epidermal growth factor receptor 2-positive (HER2+) breast cancers. While it is well documented that mammary macrophages are present within the gland, the mechanisms by which macrophages infiltrate epithelial barriers in both developmental and disease contexts remains unknown. Thus, to address this gap in our understanding of macrophage biology, we employ 3D mammary epithelial and macrophage co-cultures compatible with live imaging. We hypothesize that macrophages respond to transient disruption in epithelial integrity-such as those occurring during mitosis or programmed cell death-and use these short-lived losses of epithelial-epithelial adhesions as opportunities to access epithelial compartments. To examine this hypothesis, we have live imaged 3D mammary epithelial spheroids generated from healthy (MCF10A) and TNBC (MDA-MB-231) cells in co-culture with macrophages. Mammary acini form polarized lumen where apoptotic cells are extruded into the luminal space, like in vivo. Mammary spheroids present an in vitro model where apoptosis can be driven pharmacologically, resulting in increased epithelial turnover, allowing us to model dynamic conditions of the mammary duct. Our data support the hypothesis that macrophages traverse epithelial layers at sites of cell division, consistent with a model in which transient junctional instability guides macrophage positioning. During involution, luminal epithelial cells undergo apoptosis and release “find-me” signals into the tissue microenvironment. We hypothesize macrophages respond to these local attractants, exploiting the transient losses in epithelial-epithelial cell adhesion, to traverse the myoepithelial layer. Together, this work aims to define the epithelial cues that regulate macrophage infiltration into mammary tissues and to understand how these processes shape both normal developmental programs and early disease transition in TNBC. Elucidating the mechanisms of macrophage entry into epithelial environments may reveal new opportunities for targeting immune-epithelial interactions in aggressive breast cancers while enriching our understanding of underappreciated immune-epithelial crosstalk.
利益披露 Disclosure
E. A. Pratt, None.. M. Akhmanova, None.

← 返回 AACR 2026 检索